» Articles » PMID: 39455592

Mefloquine-induced Conformational Shift in Cx36 N-terminal Helix Leading to Channel Closure Mediated by Lipid Bilayer

Overview
Journal Nat Commun
Specialty Biology
Date 2024 Oct 25
PMID 39455592
Authors
Affiliations
Soon will be listed here.
Abstract

Connexin 36 (Cx36) forms interneuronal gap junctions, establishing electrical synapses for rapid synaptic transmission. In disease conditions, inhibiting Cx36 gap junction channels (GJCs) is beneficial, as it prevents abnormal synchronous neuronal firing and apoptotic signal propagation, mitigating seizures and progressive cell death. Here, we present cryo-electron microscopy structures of human Cx36 GJC in complex with known channel inhibitors, such as mefloquine, arachidonic acid, and 1-hexanol. Notably, these inhibitors competitively bind to the binding pocket of the N-terminal helices (NTH), inducing a conformational shift from the pore-lining NTH (PLN) state to the flexible NTH (FN) state. This leads to the obstruction of the channel pore by flat double-layer densities of lipids. These studies elucidate the molecular mechanisms of how Cx36 GJC can be modulated by inhibitors, providing valuable insights into potential therapeutic applications.

References
1.
Slater S, Malinowski S, Stubbs C . The nature of the hydrophobic n-alkanol binding site within the C1 domains of protein kinase Calpha. Biochemistry. 2004; 43(23):7601-9. DOI: 10.1021/bi049755z. View

2.
Li Q, Ma T, Qiu Y, Cui W, Chen T, Zhang W . Connexin 36 Mediates Orofacial Pain Hypersensitivity Through GluK2 and TRPA1. Neurosci Bull. 2020; 36(12):1484-1499. PMC: 7719140. DOI: 10.1007/s12264-020-00594-4. View

3.
Gajda Z, Szupera Z, Blazso G, Szente M . Quinine, a blocker of neuronal cx36 channels, suppresses seizure activity in rat neocortex in vivo. Epilepsia. 2005; 46(10):1581-91. DOI: 10.1111/j.1528-1167.2005.00254.x. View

4.
Lee S, Cho H, Jeong H, Ryu B, Lee H, Kim M . Cryo-EM structures of human Cx36/GJD2 neuronal gap junction channel. Nat Commun. 2023; 14(1):1347. PMC: 10008584. DOI: 10.1038/s41467-023-37040-8. View

5.
Juszczak G, Swiergiel A . Properties of gap junction blockers and their behavioural, cognitive and electrophysiological effects: animal and human studies. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33(2):181-98. DOI: 10.1016/j.pnpbp.2008.12.014. View